TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei February 8, 1991
TCL Archive In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel March 25, 1988
TCL Archive Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds January 29, 2010
